Ocular Surface Review

OSD Management in Glaucoma Patients

How to minimize the use of drops while treating both conditions.
08/15/2024

As Smooth As Silk

This unique protein is a brand new DED treatment.
05/15/2024

Shining the Slit Lamp on ADCs

ODs can greatly help ovarian cancer patients who are taking this advanced therapeutic agent, specifically Elahere.
03/15/2024

Not So Benign OSD

If your patient isn’t responding to treatment, look beyond the typical forms of ocular surface disease.
11/15/2023

Call the Exterminator

A new eye drop, Xdemvy, shows positive results in wiping out the unusually common condition known as Demodex blepharitis.
09/15/2023

First of its Kind

Miebo now gives us a medication option that targets MGD and evaporative DED.
07/15/2023

Drink Up

Hydrating the whole body—not just the eyes—is key to improving the ocular surface.
05/15/2023

Toxic Work Environment

Be aware of certain glaucoma therapy options that could harm the ocular surface.
03/15/2023

Right Tool for the Job

These small but mighty instruments can help you better perform a number of procedures and will enhance your practice.
02/15/2023

Making the Grade

Studies show promising results for CyclASol, a new medication to treat DED that could be approved next year.
11/15/2022

Upcoming Events

November 6, 2024

Showcasing Inflammation and IOP Control
Location: Prime 47
Presenters: Marc Bloomenstein, OD, and Nora Lee Cothran, OD
Time: 7:00pm CT

Sponsored by Bausch + Lomb

Register here

November 13, 2024

Rethinking Dry Eye Disease: A Contemporary Approach to a Complex Condition
Location: Virtual
Presenters: Harry Boparai, OD, and Doug Katsev, MD
Webinar: 7:00pm PT

Sponsored by Bausch + Lomb

Register here

November 13, 2024

The 3 I's of Geographic Atrophy: Imaging, Identification, and Intervention
Location: Virtual
Presenters: Jordana Fein, MD, and Julie Rodman, OD, MS, 
Webinar: 9:30pm ET


Sponsored by Apellis

Register here